Significance of ferritin expression in formation of malignant phenotype of human breast cancer cells
Aim: The aim of our study is to investigate the disorders of ferritin functioning in breast cancer (BC) cells of different molecular subtype. Materials and Methods: The cell lines used in the analysis include T47D, MCF-7, MDA-MB-231, MDA-MB-468, MCF-10A, and 184A1. Ferritin heavy chains (FTH) expres...
Saved in:
| Published in: | Experimental Oncology |
|---|---|
| Date: | 2014 |
| Main Authors: | Chekhun, S.V., Lukyanova, N.Y., Shvets, Y.V., Burlaka, A.P., Buchynska, L.G. |
| Format: | Article |
| Language: | English |
| Published: |
Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України
2014
|
| Subjects: | |
| Online Access: | https://nasplib.isofts.kiev.ua/handle/123456789/145363 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Journal Title: | Digital Library of Periodicals of National Academy of Sciences of Ukraine |
| Cite this: | Significance of ferritin expression in formation of malignant phenotype of human breast cancer cells / S.V. Chekhun, N.Y. Lukyanova, Y.V. Shvets, A.P. Burlaka, L.G. Buchynska // Experimental Oncology. — 2014. — Т. 36, № 3. — С. 179-183. — Бібліогр.: 31 назв. — англ. |
Institution
Digital Library of Periodicals of National Academy of Sciences of UkraineSimilar Items
Significance of ferritin expression in formation of malignant phenotype of human breast cancer cells
by: S. V. Chekhun, et al.
Published: (2014)
by: S. V. Chekhun, et al.
Published: (2014)
A study of transferrin and ferritin expression in tumor cells of patients with breast cancer
by: Shepil, O.V., et al.
Published: (2014)
by: Shepil, O.V., et al.
Published: (2014)
A study of transferrin and ferritin expression in tumor cells of patients with breast cancer
by: O. V. Shepil, et al.
Published: (2014)
by: O. V. Shepil, et al.
Published: (2014)
Hepcidin as a possible marker in determination of malignancy degree and sensitivity of breast cancer cells to cytostatic drugs
by: Yalovenko, T.M., et al.
Published: (2016)
by: Yalovenko, T.M., et al.
Published: (2016)
Clinical significance of hormonal receptor status of malignant ovarian tumors
by: Tkalia, I.G., et al.
Published: (2014)
by: Tkalia, I.G., et al.
Published: (2014)
Effect of 5-azacytidine on mirna expression in human breast cancer cells with different sensitivity to cytostatics
by: Chekhun, V.F., et al.
Published: (2016)
by: Chekhun, V.F., et al.
Published: (2016)
Correlation of iodine symporter expression in highly and low malignant cell lines of human breast cancer differed in their sensitivity to doxorubicin
by: Lukianova, N.Yu., et al.
Published: (2016)
by: Lukianova, N.Yu., et al.
Published: (2016)
Modifying effects of lactoferrin in vitro on molecular phenotype of human breast cancer cells
by: Chekhun, V.F., et al.
Published: (2015)
by: Chekhun, V.F., et al.
Published: (2015)
Expression of biomarkers related to cell adhesion, metastasis and invasion of breast cancer cell lines of different molecular subtype
by: Chekhun, S., et al.
Published: (2013)
by: Chekhun, S., et al.
Published: (2013)
Influence of exogenous lactoferrin on the oxidant/ antioxidant balance and molecular profile of hormone receptor-positive and -negative human breast cancer cells in vitro
by: Zalutski, I.V., et al.
Published: (2017)
by: Zalutski, I.V., et al.
Published: (2017)
Expression of CD40 by the cells of benign and malignant breast tumors and antitumor action of autologous lymphocytes against chemoresistant and chemosensitive tumors
by: Bereznaya, N.M., et al.
Published: (2008)
by: Bereznaya, N.M., et al.
Published: (2008)
Effects of exogenous lactoferrin on phenotypic profile and invasiveness of human prostate cancer cells (DU145 and LNCaP) in vitro
by: Zadvornyi, T.V., et al.
Published: (2018)
by: Zadvornyi, T.V., et al.
Published: (2018)
Lactoferrin expression in breast cancer in relation to biologic properties of tumors and clinical features of disease
by: Naleskina, L.A., et al.
Published: (2016)
by: Naleskina, L.A., et al.
Published: (2016)
Artemisinin modulating effect on human breast cancer cell lines with different sensitivity to cytostatics
by: Chekhun, V.F., et al.
Published: (2017)
by: Chekhun, V.F., et al.
Published: (2017)
Significance of adhesion molecules expression for estimation of serous ovarian cancer prognosis
by: Ryabtseva, O.D., et al.
Published: (2013)
by: Ryabtseva, O.D., et al.
Published: (2013)
Characteristics of homocysteine-induced multidrug resistance of human MCF-7 breast cancer cells and human A2780 ovarian cancer cells
by: Lukyanova, N.Yu.
Published: (2010)
by: Lukyanova, N.Yu.
Published: (2010)
Comprehensive analysis of intratumoral lymphocytes and FOXP3 expression in tumor cells of endometrial cancer
by: Lurchenko, N.P., et al.
Published: (2014)
by: Lurchenko, N.P., et al.
Published: (2014)
Metabolic disorder of iron and ferritin in patients with breast cancer (literature sources review)
by: O. V. Shepil
Published: (2014)
by: O. V. Shepil
Published: (2014)
Peculiarities of antioxidant system and iron metabolism in organism during development of tumor resistance to cisplatin
by: Chekhun, V.F., et al.
Published: (2014)
by: Chekhun, V.F., et al.
Published: (2014)
Expression of cancer-associated genes in prostate tumors
by: Rosenberg, E.E., et al.
Published: (2017)
by: Rosenberg, E.E., et al.
Published: (2017)
The lipid content of cisplatin- and doxorubicin-resistant MCF-7 human breast cancer cells
by: Todor, I.N., et al.
Published: (2012)
by: Todor, I.N., et al.
Published: (2012)
TRP genes family expression in colorectal cancer
by: Sozucan, Y., et al.
Published: (2015)
by: Sozucan, Y., et al.
Published: (2015)
Distribution and accumulation of liposomal form of doxorubicin in breast cancer cells of MCF-7 line
by: Rusetskaya, N.V., et al.
Published: (2011)
by: Rusetskaya, N.V., et al.
Published: (2011)
The role of cardiac biomarkers as predictors of trastuzumab cardiotoxicity in patients with breast cancer
by: Ürün, Y., et al.
Published: (2015)
by: Ürün, Y., et al.
Published: (2015)
СD44+/CD24− markers of cancer stem cells in patients with breast cancer of different molecular subtypes
by: Chekhun, S.V., et al.
Published: (2015)
by: Chekhun, S.V., et al.
Published: (2015)
Survivin expression in ovarian cancer
by: Liguang, Z., et al.
Published: (2007)
by: Liguang, Z., et al.
Published: (2007)
Are CD44⁺/CD24⁻ cells the assumed cancer stem cells in breast cancer?
by: Ryspayeva, D.E., et al.
Published: (2017)
by: Ryspayeva, D.E., et al.
Published: (2017)
Dihydropyrimidine dehydrogenase activity correlates with fluorouracil sensitivity in breast cancer
by: Yu, Z., et al.
Published: (2007)
by: Yu, Z., et al.
Published: (2007)
Aspisol inhibits tumor growth and induces apoptosis in breast cancer
by: Zhu, X.G., et al.
Published: (2008)
by: Zhu, X.G., et al.
Published: (2008)
Genetic polymorphisms of the renin-angiotensin system in breast cancer patients
by: Fishchuk, L.E., et al.
Published: (2013)
by: Fishchuk, L.E., et al.
Published: (2013)
Impact of stromal cell components of tumor microenvironment on epithelial-mesenchymal transition in breast cancer cells
by: Bezdenezhnykh, N., et al.
Published: (2014)
by: Bezdenezhnykh, N., et al.
Published: (2014)
Relationship between NF-κB, ER, PR, Her2/neu, Ki67, p53 expression in human breast cancer
by: Shapochka, D.O., et al.
Published: (2012)
by: Shapochka, D.O., et al.
Published: (2012)
The study of mismatch repair in endometrial cancer patients with a family history of cancer
by: Buchynska, L.G., et al.
Published: (2015)
by: Buchynska, L.G., et al.
Published: (2015)
Features of hepcidin expression in patients with breast cancer
by: Yu. Lukianova, et al.
Published: (2015)
by: Yu. Lukianova, et al.
Published: (2015)
Sensitivity to 4-hydroxyestradiol and dna repair efficiency in peripheral blood lymphocytes of endometrial cancer patients
by: Buchynska, L.G., et al.
Published: (2018)
by: Buchynska, L.G., et al.
Published: (2018)
OX40L gene polymorphism and breast cancer in Iranian population
by: Vakil Monfared, R., et al.
Published: (2018)
by: Vakil Monfared, R., et al.
Published: (2018)
High body-mass index is not associated with worse clinicopathological characteristics in predominantly obese breast cancer patients
by: Kemal, Y., et al.
Published: (2015)
by: Kemal, Y., et al.
Published: (2015)
The Clinical Significance of Tumor MIR-122, -155, -182, and -200b Expression in Patients with Breast Cancer
by: V. F. Chekhun, et al.
Published: (2017)
by: V. F. Chekhun, et al.
Published: (2017)
Differential expression of CD150/SLAMF1 in normal and malignant b cells on the different stages of maturation
by: Gordiienko, I.M., et al.
Published: (2016)
by: Gordiienko, I.M., et al.
Published: (2016)
Down-regulation of ABCC11 protein (MRP8) in human breast cancer
by: Sosonkina, N., et al.
Published: (2011)
by: Sosonkina, N., et al.
Published: (2011)
Similar Items
-
Significance of ferritin expression in formation of malignant phenotype of human breast cancer cells
by: S. V. Chekhun, et al.
Published: (2014) -
A study of transferrin and ferritin expression in tumor cells of patients with breast cancer
by: Shepil, O.V., et al.
Published: (2014) -
A study of transferrin and ferritin expression in tumor cells of patients with breast cancer
by: O. V. Shepil, et al.
Published: (2014) -
Hepcidin as a possible marker in determination of malignancy degree and sensitivity of breast cancer cells to cytostatic drugs
by: Yalovenko, T.M., et al.
Published: (2016) -
Clinical significance of hormonal receptor status of malignant ovarian tumors
by: Tkalia, I.G., et al.
Published: (2014)